Literature DB >> 8185702

Magnetic resonance imaging and P-31 magnetic resonance spectroscopy provide unique quantitative data useful in the longitudinal management of patients with dermatomyositis.

J H Park1, T L Vital, N M Ryder, M Hernanz-Schulman, C L Partain, R R Price, N J Olsen.   

Abstract

OBJECTIVE: To evaluate the utility of magnetic resonance imaging (MRI) and P-31 magnetic resonance spectroscopy (MRS) in the longitudinal management of patients with dermatomyositis (DM).
METHODS: The study group consisted of 11 patients, including 3 children, all of whom had a clinical diagnosis of DM. A control group of 8 subjects was studied simultaneously. MRI included images as well as calculations of T1 and T2 relaxation times. The P-31 MRS protocol evaluated metabolic status (i.e., inorganic phosphate/phosphocreatine ratios and phosphocreatine and ATP levels) during rest, exercise, and recovery.
RESULTS: T2-weighted images of the thigh muscles showed inflammation even when serum creatine phosphokinase levels were in the normal range. Metabolic abnormalities, which were accentuated with exercise, were found in 10 patients. In some individuals, bioenergetic defects preceded other changes and persisted after resolution of inflammation. In general, clinical impressions correlated with MRI/MRS data.
CONCLUSION: MRI and MRS provide unique data which are quantitative and which cannot be obtained from routine laboratory tests. These MR evaluations appear to be of value in assessing the status of DM patients during treatment with steroids and immunosuppressive drugs.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8185702     DOI: 10.1002/art.1780370519

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  15 in total

Review 1.  Imaging and skeletal muscle disease.

Authors:  Nancy J Olsen; Jing Qi; Jane H Park
Journal:  Curr Rheumatol Rep       Date:  2005-04       Impact factor: 4.592

2.  Quantitative Magnetic Resonance Imaging of Skeletal Muscle Disease.

Authors:  Bruce M Damon; Ke Li; Richard D Dortch; E Brian Welch; Jane H Park; Amanda K W Buck; Theodore F Towse; Mark D Does; Daniel F Gochberg; Nathan D Bryant
Journal:  J Vis Exp       Date:  2016-12-18       Impact factor: 1.355

3.  Multi-parametric MRI characterization of healthy human thigh muscles at 3.0 T - relaxation, magnetization transfer, fat/water, and diffusion tensor imaging.

Authors:  Ke Li; Richard D Dortch; E Brian Welch; Nathan D Bryant; Amanda K W Buck; Theodore F Towse; Daniel F Gochberg; Mark D Does; Bruce M Damon; Jane H Park
Journal:  NMR Biomed       Date:  2014-07-26       Impact factor: 4.044

Review 4.  Amyopathic dermatomyositis.

Authors:  N J Olsen; J H Park; L E King
Journal:  Curr Rheumatol Rep       Date:  2001-08       Impact factor: 4.592

5.  Signs of inflammation in both symptomatic and asymptomatic muscles from patients with polymyositis and dermatomyositis.

Authors:  C Dorph; P Englund; I Nennesmo; I E Lundberg
Journal:  Ann Rheum Dis       Date:  2006-07-10       Impact factor: 19.103

Review 6.  Creatine for treating muscle disorders.

Authors:  Rudolf A Kley; Mark A Tarnopolsky; Matthias Vorgerd
Journal:  Cochrane Database Syst Rev       Date:  2013-06-05

Review 7.  Evidence for metabolic abnormalities in the muscles of patients with fibromyalgia.

Authors:  J H Park; K J Niermann; N Olsen
Journal:  Curr Rheumatol Rep       Date:  2000-04       Impact factor: 4.592

Review 8.  Drug treatment for facioscapulohumeral muscular dystrophy.

Authors:  M R Rose; R Tawil
Journal:  Cochrane Database Syst Rev       Date:  2004

Review 9.  Laboratory evaluation of the inflammatory myopathies.

Authors:  L G Rider; F W Miller
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

Review 10.  Inflammatory muscle disease: clinical presentation and assessment of patients.

Authors:  Helene Alexanderson; Ingrid E Lundberg
Journal:  Curr Rheumatol Rep       Date:  2007-08       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.